12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Deals

Oncolys BioPharma, Bristol-Myers deal

Bristol-Myers received exclusive, worldwide rights to develop and commercialize Oncolys' festinavir. Oncolys is eligible for up...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >